Akari Therapeutics, Plc (NASDAQ:AKTX) Short Interest Update
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) saw a significant decline in short interest in the month of February. As of February 15th, there was short interest totalling 77,700 shares, a decline of 38.7% from the January 31st total of 126,800 shares. Currently, 0.6% of the shares of the company are sold short. Based […]
